BOOK A MEETING
Decentralised clinical trials offer many benefits such as improved patient access and enhanced recruitment, but they present unique challenges for clinical trial operations teams. The complexities of running decentralised studies and complex participant schedules can place a heavy burden on study teams.
This blog post article will focus on overcoming these challenges and how our approach to unified trial delivery helps reduce study team burden and the time and effort required to manage trials effectively.
Decentralised trials involve participants from various locations, each with their own schedules and requirements. Coordinating and managing these schedules can be challenging, leading to potential delays and decreased patient satisfaction.
As clinical trials become more complex, the burden on the study teams grows. They face numerous tasks, communication hurdles, and documentation requirements, which can lead to burnout and reduced productivity.
The consequences of not addressing these challenges include delays or failures in clinical trials, poor data quality, and the undermining of trial results' validity.
At Lindus Health, we understand the complexities faced by clinical trial professionals in managing decentralised trials. Our approach focuses on two core principles:
Our unified Citrus platform enables study teams to manage decentralised trials and complex participant schedules seamlessly. With real-time visibility into trial progress, teams can quickly address issues and make data-driven decisions.
Our platform simplifies the management of participant and study team flows, ensuring that all study visits, procedures, and documentation are completed on time. This not only reduces the administrative burden on study teams but also improves patient compliance and data quality.
As seen in the screenshot of our Citrus platform below, the site and study team can see all upcoming assessments for trial participants.
Decentralised clinical trials offer significant advantages, but they also introduce new challenges. By centralising management and streamlining participant and study team flows, Lindus Health supports health and biotech pioneers to overcome these hurdles and achieve on-time and on-budget study completion.
Get in touch to learn how Lindus Health can accelerate your next clinical trial.
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
Lindus Health aims to enhance the efficiency and success rates of CNS, neurology and psychiatric clinical trials with its "All-in-One CRO" offering to this market segment.
Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
Now available: Lindus Health's "All-In-One Metabolic CRO" to accelerate and streamline research in metabolic conditions such as diabetes, obesity, NASH, and more.
Running Effective DTx Studies in EU Markets, and Considerations for Cross Country Data Acceptance
As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.